Marketo Inc. (NASDAQ:MKTO), the leading provider of marketing software, announced it has been positioned by Gartner, Inc. in the “Visionaries” quadrant in the Magic Quadrant for Multichannel Campaign Management (MCCM). Marketo Inc (NASDAQ:MKTO) net profit margin is -46.50% and weekly performance is -12.28%. On last trading day company shares ended up $22.35. Analysts mean target price for the company is $40.83. Marketo Inc (NASDAQ:MKTO) distance from 50-day simple moving average (SMA50) is -21.55%.
Goldman Sachs initiated coverage on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $93.00 price target on the stock. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) shares advanced 1.76% in last trading session and ended the day on $81.00. Gross Margin is 44.40% and its return on assets is -44.10%. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) quarterly performance is 0.71%.
NQ Mobile Inc (ADR) (NYSE:NQ) is accused of misrepresenting the revenue figures which has led in the gain in the share prices. This Chinese mobile-service provider was accused by the Carson Block, founder of a Muddy Waters LLC in October last year. The company has somewhat gained the most after increasing its forecast and selling a stake in a subsidiary. NQ Mobile Inc (ADR) (NYSE:NQ) first quarter revenue is expected to be above its previous estimates. The company also gave a strong guidance for the second quarter results. The management of the company issued a separate statement that it will be selling a minority stake in its FL Mobile gaming subsidiary for nearly $25 million. NQ Mobile Inc (ADR) (NYSE:NQ) shares moved down -0.78% in last trading session and was closed at $7.63, while trading in range of $7.32 – $7.69. NQ Mobile Inc (ADR) (NYSE:NQ) year to date (YTD) performance is -48.10%.
Goldman Sachs initiates coverage on Exact Sciences Corporation (NASDAQ:EXAS) with a Buy rating and a price target of $19.00, suggesting 39% upside. The firm said the company’s Cologuard is changing the paradigm in CRC screening. EXACT Sciences Corporation (NASDAQ:EXAS) ended the last trading day at $13.65. Company weekly volatility is calculated as 3.63% and price to cash ratio as 9.74. EXACT Sciences Corporation (NASDAQ:EXAS) showed a negative weekly performance of -0.66%.
Hemp, Inc. (OTCMKTS:HEMP) announced its support of the 5th Annual Hemp History Week from June 2 through June 8, 2014. The week long awareness campaign, themed “It’s Time to Grow”, features thousands of events across the country (including movie screenings of “Bringing it Home” and “The Emperor of Hemp”) in an effort to educate and raise awareness regarding the environmental and nutritional benefits of Industrial Hemp and hemp-based products. HEMP, INC. (OTCMKTS:HEMP) On last trading day company shares ended up $0.0620.